Pain predicts overall survival in men with metastatic castration-refractory prostate cancer.
- Citation:
- J Clin Oncol vol 26 (15) 2544-9
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA 36601
- Corr. Author:
- Authors:
- Susan Halabi Nicholas J Vogelzang Alice B Kornblith San-San Ou Philip W Kantoff Nancy A Dawson Eric J Small
- Networks:
- Study
- CALGB-9840
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-9181, CALGB-9182
- Phases:
- 3, 2, 3
- Keywords:
- Adenocarcinoma, Aged, Antineoplastic Agents, Bone Neoplasms, Clinical Trials, Phase III as Topic, Humans, Male, Multicenter Studies as Topic, Neoplasms, Hormone-Dependent, Orchiectomy, Pain Measurement, Prostatic Neoplasms, Randomized Controlled Trials as Topic, Statistics as Topic